An under-the-radar Bay Area biotech has brought in a $190 million series B with the goal of hatching a clutch of new companies to fly its drug candidates forward.
Discreet biotech Osanni Bio starts making noise with $190M series B for clinical push
September 7, 2026
Breaking
Analyst: Bitcoin Experiences Sharpest Deleveraging Since 2023
Bitcoin Hits Roadblock at $82,850 as $1B Crypto ETF Draws Investors – Jupiter and Zcash Soar
Bitcoin’s Value Under Fire: Peter Schiff Reignites the Age-Old Debate
Jiang Zhuoer Unloads Bitcoin: Warning of a Major Price Dip to $76,000 Liquidation Zone